Predicting immunoglobulin resistance in Kawasaki disease: an assessment of neutrophil to lymphocyte platelet ratio

Ital J Pediatr. 2022 Dec 30;48(1):208. doi: 10.1186/s13052-022-01400-9.

Abstract

Background: Kawasaki disease (KD) is an acute febrile illness of unknown etiology and predictors for intravenous immunoglobulin (IVIG) resistance have been widely explored in recent decades. Neutrophil to lymphocyte platelet ratio (NLPR) was reported to be associated with the outcomes in many diseases. However, its relationship with IVIG resistance has not be explored.

Methods: The medical data of patients diagnosed with KD in Children's Hospital of Soochow University between January 2019 and December 2020 were retrospectively reviewed and analyzed. Patients were trisected into three groups based on NLPR. Logistics regression was used to analyze the association between NLPR and IVIG resistance. Restricted cubic spine was used to exhibit the relationship. Sensitivity analysis and subgroup analysis were also carried out.

Results: A total of 803 patients were included in the present study (61.8% males; median age: 24 months). IVIG resistance occurred in 74 (9.2%) patients. Multivariable-adjusted analyses revealed higher NLPR (odds ratio [95% confidence interval]: 1.12 [1.00-1.24]) was an independent predictor of IVIG resistance, which was strengthened by sensitivity analyses. The association of NLPR and IVIG resistance was not modified by age, sex, CALs, or days of IVIG initiation ≤ 4.

Conclusion: NLPR may be a valuable prognostic marker in KD patients with IVIG resistance.

Keywords: Children; Intravenous immunoglobulin resistance; Kawasaki disease; Neutrophil to lymphocyte platelet ratio.

MeSH terms

  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunoglobulins, Intravenous* / therapeutic use
  • Infant
  • Lymphocytes
  • Male
  • Mucocutaneous Lymph Node Syndrome* / diagnosis
  • Mucocutaneous Lymph Node Syndrome* / drug therapy
  • Neutrophils
  • Retrospective Studies

Substances

  • Immunoglobulins, Intravenous